Development and Application of Computational Methods in Biology and Medicine

Author(s): Zunnan Huang, Ruo-Xu Gu.

Journal Name: Current Medicinal Chemistry

Volume 26 , Issue 42 , 2019

[1]
Zeng, J.; Huang, Z. From Levinthal’s paradox to the effects of cell environmental perturbation on protein folding. Curr. Med. Chem., 2019, 26(42), 7537-7554.
[2]
Sulimov, V.B.; Kutov, D.C.; Sulimov, A.V. Advances in docking. Curr. Med. Chem., 2019, 26(42), 7555-7580.
[3]
Yang, J.F.; Wang, D.; Jia, C.; Wang, M.; Hao, G.F.; Yang, G.F. Freely accessible chemical database resources of compounds for in silico drug discovery. Curr. Med. Chem., 2019, 26(42), 7581-7597.
[4]
Hu, X.; Maffucci, I.; Contini, A. Advances in the treatment of explicit water molecules in docking and binding free energy calculations. Curr. Med. Chem., 2019, 26(42), 7598-7622.
[5]
Kim, C.; Kim, E. Rational drug design approach of receptor tyrosine kinase type III inhibitors. Curr. Med. Chem., 2019, 26(42), 7623-7640.
[6]
Ma, T. Ye, Z.; Wang, L. Genome wide approaches to identify protein-DNA interactions. Curr. Med. Chem., 2019, 26(42), 7641-7654.
[7]
Zou, J.; Wang, E. Cancer biomarker discovery for precision medicine: new progresses. Curr. Med. Chem., 2019, 26(42), 7655-7671.
[8]
He, B.; Dzisoo, A.M.; Derda, R.; Huang, J. Development and application of computational methods in phase display technology. Curr. Med. Chem., 2019, 26(42), 7672-7693.
[9]
Selvaraj, G.; Kaliamurthi, S.; Lin, S.; Gu, K.; Wei, D-Q. Prognostic impact of tissue inhibitor of Metalloproteinase-1 in non-small cell lung cancer: Systematic review and meta-analysis. Curr. Med. Chem., 2019, 26(42), 7694-7713.


Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 26
ISSUE: 42
Year: 2019
Page: [7534 - 7536]
Pages: 3
DOI: 10.2174/092986732642200108101400

Article Metrics

PDF: 25
HTML: 5
PRC: 1